| Michelle Cavanaugh, | |
|
145 Shaffer St, South Williamsport, PA 17702-6727 | |
| (570) 326-2447 | |
| Not Available |
| Full Name | Michelle Cavanaugh |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 145 Shaffer St, South Williamsport, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023082351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD069473L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Susquehanna Home Care And Hospice Services | Williamsport, PA | Home health agency |
| Susquehanna Home Care & Hospice Services | Williamsport, PA | Hospice |
| Williamsport Regional Medical Center | Williamsport, PA | Hospital |
| Upmc Wellsboro | Wellsboro, PA | Hospital |
| Upmc Susquehanna Muncy | Muncy, PA | Hospital |
| Geisinger Jersey Shore Hospital | Jersey shore, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Susquehanna Physician Services | 2264336460 | 492 |
News Archive
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx's product portfolio.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has reached an agreement to close on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited.
A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.
Scientists from the Uniformed Services University of the Health Sciences (USU) have discovered that diets high in salt may increase the virulence of the pathogen Helicobacter pylori (H. pylori), which is the most common cause of ulcers in the stomach and duodenum.
According to the Centers for Disease Control and Prevention (CDC), 37 states in the U.S. now report widespread influenza activity - and nearly all influenza cases reported to the health authority are 2009 H1N1, also known as swine flu. However, with the release of a 2009 H1N1 vaccine this week, parents have a new preventative tool to help keep their families safe from illness.
› Verified 4 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780631226 PECOS PAC ID: 2264336460 Enrollment ID: O20040709000444 |
News Archive
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx's product portfolio.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has reached an agreement to close on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited.
A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.
Scientists from the Uniformed Services University of the Health Sciences (USU) have discovered that diets high in salt may increase the virulence of the pathogen Helicobacter pylori (H. pylori), which is the most common cause of ulcers in the stomach and duodenum.
According to the Centers for Disease Control and Prevention (CDC), 37 states in the U.S. now report widespread influenza activity - and nearly all influenza cases reported to the health authority are 2009 H1N1, also known as swine flu. However, with the release of a 2009 H1N1 vaccine this week, parents have a new preventative tool to help keep their families safe from illness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Cavanaugh, 1201 Grampian Blvd, Williamsport, PA 17701-1900 Ph: () - | Michelle Cavanaugh, 145 Shaffer St, South Williamsport, PA 17702-6727 Ph: (570) 326-2447 |
News Archive
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx's product portfolio.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has reached an agreement to close on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited.
A new study suggests that a substance made by immune cells plays a key role in the progression of a disease in animals that closely mimics multiple sclerosis (MS). The findings further suggest that blocking the molecule, known as macrophage migration inhibitory factor (MIF) might prevent the progression of the disease.
Scientists from the Uniformed Services University of the Health Sciences (USU) have discovered that diets high in salt may increase the virulence of the pathogen Helicobacter pylori (H. pylori), which is the most common cause of ulcers in the stomach and duodenum.
According to the Centers for Disease Control and Prevention (CDC), 37 states in the U.S. now report widespread influenza activity - and nearly all influenza cases reported to the health authority are 2009 H1N1, also known as swine flu. However, with the release of a 2009 H1N1 vaccine this week, parents have a new preventative tool to help keep their families safe from illness.
› Verified 4 days ago
Dr. Terry Alan Belles, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 145 Shaffer St, South Williamsport, PA 17702 Phone: 570-326-2447 Fax: 570-326-1247 | |
Dr. Glen Theodore Hofstrom, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 145 Shaffer St, South Williamsport, PA 17702 Phone: 570-326-2447 Fax: 570-326-1247 | |
Sara Swain, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 Shaffer St, South Williamsport, PA 17702 Phone: 570-326-2447 |